SEARCH

SEARCH BY CITATION

References

  • Allen, S.J., Wilcock, G.K. & Dawbarn, D. (1999) Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer’s disease. Biochem Biophys Res Commun 264, 648651.
  • Asada, T., Yamagata, Z., Kinoshita, T., Kinoshita, A., Kariya, T., Asaka, A. & Kakuma, T. (1996) Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc 44, 151155.
  • Ashburner, J., Andersson, J.L. & Friston, K.J. (1999) High-dimensional image registration using symmetric priors. Neuroimage 9, 619628.
  • Ashford, J.W. & Mortimer, J.A. (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J Alzheimers Dis 4, 169177.
  • Barnes, J., Scahill, R.I., Schott, J.M., Frost, C., Rossor, M.N. & Fox, N.C. (2005a) Does Alzheimer’s disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord 19, 338344.
  • Barnes, L.L., Wilson, R.S., Bienias, J.L., Schneider, J.A., Evans, D.A. & Bennett, D.A. (2005b) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62, 685691.
  • Berg, L. (1988) Clinical dementia rating (CDR). Psychopharmacol Bull 24, 637639.
  • Bian, J.T., Zhang, J.W., Zhang, Z.X. & Zhao, H.L. (2005) Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer’s disease (AD) in mainland Chinese. Neurosci Lett 387, 1116.
  • Bodner, S.M., Berrettini, W., Van Deerlin, V., Bennett, D.A., Wilson, R.S., Trojanowski, J.Q. & Arnold, S.E. (2005) Genetic variation in the brain derived neurotrophic factor gene in Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet 134, 15.
  • Bondi, M.W., Salmon, D.P., Galasko, D., Thomas, R.G. & Thal, L.J. (1999) Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer’s disease. Psychol Aging 14, 295303.
  • Braak, E., Braak, H. & Mandelkow, E.M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87, 554567.
  • Chen, Z.Y., Patel, P.D., Sant, G., Meng, C.X., Teng, K.K., Hempstead, B.L. & Lee, F.S. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24, 44014411.
  • Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. & Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921923.
  • Craft, S., Teri, L., Edland, S.D., Kukull, W.A., Schellenberg, G., McCormick, W.C., Bowen, J.D. & Larson, E.B. (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer’s disease. Neurology 51, 149153.
  • Delacourte, A., David, J.P., Sergeant, N., Buee, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., Petit, H. & Di Menza, C. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52, 11581165.
  • Desai, P., Nebes, R., DeKosky, S.T. & Kamboh, M.I. (2005) Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer’s disease (AD) and quantitative measures of AD progression. Neurosci Lett 379, 229234.
  • Du, A.T., Schuff, N., Chao, L.L., Kornak, J., Jagust, W.J., Kramer, J.H., Reed, B.R., Miller, B.L., Norman, D., Chui, H.C. & Weiner, M.W. (2006) Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 27, 733740.
  • Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. & Weinberger, D.R. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257269.
  • Farlow, M.R., He, Y., Tekin, S., Xu, J., Lane, R. & Charles, H.C. (2004) Impact of APOE in mild cognitive impairment. Neurology 63, 18981901.
  • Fleisher, A., Grundman, M., Jack, C.R. Jr, Petersen, R.C., Taylor, C., Kim, H.T., Schiller, D.H., Bagwell, V., Sencakova, D., Weiner, M.F., DeCarli, C., DeKosky, S.T., Van Dyck, C.H. & Thal, L.J. (2005) Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 62, 953957.
  • Folstein, M.F., Folstein, S.E. & McHugh, P.R. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189198.
  • Fox, N.C., Crum, W.R., Scahill, R.I., Stevens, J.M., Janssen, J.C. & Rossor, M.N. (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358, 201205.
  • Frisoni, G.B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G. & Trabucchi, M. (1995) Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer’s disease. Ann Neurol 37, 596604.
  • Geroldi, C., Pihlajamaki, M., Laakso, M.P., DeCarli, C., Beltramello, A., Bianchetti, A., Soininen, H., Trabucchi, M. & Frisoni, G.B. (1999) APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53, 18251832.
  • Hamilton, M. (1980) Rating depressive patients. J Clin Psychiatry 41, 2124.
  • Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F. & Weinberger, D.R. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 66906694.
  • Den Heijer, T., Oudkerk, M., Launer, L.J., Van Duijn, C.M., Hofman, A. & Breteler, M.M. (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59, 746748.
  • Larsson, E., Nanobashvili, A., Kokaia, Z. & Lindvall, O. (1999) Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats. J Cereb Blood Flow Metab 19, 12201228.
  • Lehtovirta, M., Laakso, M.P., Soininen, H., Helisalmi, S., Mannermaa, A., Helkala, E.L., Partanen, K., Ryynanen, M., Vainio, P., Hartikainen, P. & Riekkinen, P.J. Sr. (1995) Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67, 6572.
  • Lemaitre, H., Crivello, F., Dufouil, C., Grassiot, B., Tzourio, C., Alperovitch, A. & Mazoyer, B. (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24, 12051213.
  • Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., Kunugi, H. & Koyama, T. (2006) Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr Genet 16, 4950.
  • Matsushita, S., Arai, H., Matsui, T., Yuzuriha, T., Urakami, K., Masaki, T. & Higuchi, S. (2005) Brain-derived neurotrophic factor gene polymorphisms and Alzheimer’s disease. J Neural Transm 112, 703711.
  • Mattson, M.P., Maudsley, S. & Martin, B. (2004) BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27, 589594.
  • McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34, 939944.
  • Moffat, S.D., Szekely, C.A., Zonderman, A.B., Kabani, N.J. & Resnick, S.M. (2000) Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55, 134136.
  • Nemoto, K., Ohnishi, T., Mori, T., Moriguchi, Y., Hashimoto, R., Asada, T. & Kunugi, H. (2006) The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 397, 2529.
  • Ohnishi, T., Hashimoto, R., Mori, T., Nemoto, K., Moriguchi, Y., Iida, H., Noguchi, H., Nakabayashi, T., Hori, H., Ohmori, M., Tsukue, R., Anami, K., Hirabayashi, N., Harada, S., Arima, K., Saitoh, O. & Kunugi, H. (2006) The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129, 399410.
  • Okada, T., Hashimoto, R., Numakawa, T., Iijima, Y., Kosuga, A., Tatsumi, M., Kamijima, K., Kato, T. & Kunugi, H. (2006) A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry 11, 695703.
  • Pezawas, L., Verchinski, B.A., Mattay, V.S., Callicott, J.H., Kolachana, B.S., Straub, R.E., Egan, M.F., Meyer-Lindenberg, A. & Weinberger, D.R. (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24, 1009910102.
  • Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A. & Winslow, J.W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7, 695702.
  • Puglielli, L., Tanzi, R.E. & Kovacs, D.M. (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6, 345351.
  • Reiman, E.M., Chen, K., Alexander, G.E., Caselli, R.J., Bandy, D., Osborne, D., Saunders, A.M. & Hardy, J. (2005) Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 102, 82998302.
  • Scahill, R.I., Schott, J.M., Stevens, J.M., Rossor, M.N. & Fox, N.C. (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A 99, 47034707.
  • Scahill, R.I., Frost, C., Jenkins, R., Whitwell, J.L., Rossor, M.N. & Fox, N.C. (2003) A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60, 989994.
  • Stern, Y., Brandt, J., Albert, M., Jacobs, D.M., Liu, X., Bell, K., Marder, K., Sano, M., Albert, S., Del-Castillo Castenada, C., Bylsma, F., Tycko, B. & Mayeux, R. (1997) The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer’s disease. Ann Neurol 41, 615620.
  • Szeszko, P.R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R.M., Kane, J.M., Goldman, D. & Malhotra, A.K. (2005) Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10, 631636.
  • Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A., Nadon, G., Dunn, E. & St George-Hyslop, P.H. (1996) Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology 46, 661665.
  • Tsai, S.J., Hong, C.J., Liu, H.C., Liu, T.Y., Hsu, L.E. & Lin, C.H. (2004) Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer’s disease and age of onset. Neuropsychobiology 49, 1012.
  • Ventriglia, M., Bocchio Chiavetto, L., Benussi, L., Binetti, G., Zanetti, O., Riva, M.A. & Gennarelli, M. (2002) Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Mol Psychiatry 7, 136137.